Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch

por Binkhorst, Lisette, Bannink, Marjolein, de Bruijn, Peter, Ruit, Jan, Droogendijk, Helga, van Alphen, Robbert J., den Boer, Tilly D., Lam, Mei Ho, Jager, Agnes, van Gelder, Teun, Mathijssen, Ron H. J.
Publicado 2015

Prognostic factors in men with metastatic castration-resistant prostate cancer treated with cabazitaxel

por Belderbos, Bodine P.S., de Wit, Ronald, Hoop, Esther Oomen-de, Nieuweboer, Annemieke, Hamberg, Paul, van Alphen, Robbert J., Bergman, André, van der Meer, Nelly, Bins, Sander, Mathijssen, Ron H.J., van Soest, Robert J.
Publicado 2017

The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors

por Hussaarts, Koen G. A. M., Berger, Florine A., Binkhorst, Lisette, Oomen - de Hoop, Esther, van Leeuwen, Roelof W. F., van Alphen, Robbert J., Mathijssen - van Stein, Daniëlle, de Groot, Natasja M. S., Mathijssen, Ron H. J., van Gelder, Teun
Publicado 2019

Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1, BRCA2, or ATM Alterations Identified by Testing Circulating Tumor DNA

por Matsubara, Nobuaki, de Bono, Johann, Olmos, David, Procopio, Giuseppe, Kawakami, Satoru, Ürün, Yüksel, van Alphen, Robbert, Flechon, Aude, Carducci, Michael A., Choi, Young Deuk, Hotte, Sebastien J., Korbenfeld, Ernesto, Kramer, Gero, Agarwal, Neeraj, Chi, Kim N., Dearden, Simon, Gresty, Christopher, Kang, Jinyu, Poehlein, Christian, Harrington, Elizabeth A., Hussain, Maha
Publicado 2023

Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients

por Binkhorst, Lisette, Kloth, Jacqueline S. L., de Wit, Annelieke S., de Bruijn, Peter, Lam, Mei H., Chaves, Ines, Burger, Herman, van Alphen, Robbert J., Hamberg, Paul, van Schaik, Ron H. N., Jager, Agnes, Koch, Birgit C. P., Wiemer, Erik A. C., van Gelder, Teun, van der Horst, Gijsbertus T. J., Mathijssen, Ron H. J.
Publicado 2015

Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer

por Braal, C. Louwrens, Jager, Agnes, Hoop, Esther Oomen-de, Westenberg, Justin D., Lommen, Koen M. W. T., de Bruijn, Peter, Vastbinder, Mijntje B., van Rossum-Schornagel, Quirine C., Thijs-Visser, Martine F., van Alphen, Robbert J., Struik, Liesbeth E. M., Zuetenhorst, Hanneke J. M., Mathijssen, Ron H. J., Koolen, Stijn L. W.
Publicado 2021

Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen

por Hussaarts, Koen G.A.M., Hurkmans, Daan P., Oomen-de Hoop, Esther, van Harten, Leonie J., Berghuis, Stan, van Alphen, Robbert J., Spierings, Leontine E.A., van Rossum-Schornagel, Quirine C., Vastbinder, Mijntje B., van Schaik, Ron H.N., van Gelder, Teun, Jager, Agnes, van Leeuwen, Roelof W.F., Mathijssen, Ron H.J.
Publicado 2019